Redesigning cell biology via protein engineering to enable curative cell therapies at scale.
all companies
milestones
Founded 2020
Partnered 2020
Team
Marc Lajoie
Scott Boyken
Board
LEAD INVESTOR
category
Oncology
Immunology
Pushing the boundaries of biology to create tailored cell therapy solutions through protein design and custom programming
No items found.
